Mar 27, 2024 / 05:00PM GMT
Unidentified Company Representative
Thank you, Nadia, and hello, everyone. I'm Lucie. I have the pleasure to introduce you today to Dr. Alessandro Riva, who is our Chairman and CEO, along with several members of the Executive Committee will also be here to answer your questions. We will review today's announcement, mostly in view of our exciting perspective for 2024, and we will then answer any questions you may have.
Before I turn the call to Alessandro, I'd like to remind everyone that today's discussion contains forward-looking statements, which are subject to numerous risks and uncertainties. If you're listening to this webcast via the Internet, you will not be able to ask questions. So if you wish to ask questions, please make sure that you join us via one of the conference call members or you can also send me directly an e-mail to (inaudible) and I'll be happy to read your question. With this, I now turn the call over to Alessandro Riva.
Alessandro Riva - Transgene SA - Chairman & CEO
Thank you, Lucie, and thank you for joining today's call. Before
Full Year 2023 Transgene SA Earnings Call Transcript
Mar 28, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers